Metagenomi, Inc. Common Stock (MGX) — Cash Flow-to-Debt Ratio
Latest as of June 2026:
-0.32x
Metagenomi, Inc. Common Stock (MGX) has a Cash Flow-to-Debt Ratio of -0.32x as of June 2026, meaning its operating cash flow of $-19.51 Million could theoretically repay 0% of its total liabilities ($61.13 Million) in one year. See how financially flexible is Metagenomi, Inc. Common Stock to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.32x
Operating CF / Total Liabilities
Operating Cash Flow
$-19.51 Million
USD
Total Liabilities
$61.13 Million
USD
Data as of
Jun 2026
Most recent filing
Metagenomi, Inc. Common Stock Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Metagenomi, Inc. Common Stock across 5 annual periods. For the full cash flow conversion analysis, see how efficiently does Metagenomi, Inc. Common Stock generate cash.
Annual Cash Flow-to-Debt Ratio for Metagenomi, Inc. Common Stock (2021–2025)
Year-by-year debt coverage analysis for Metagenomi, Inc. Common Stock.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.42x | $-88.89 Million | $62.51 Million | ▼ -17.0% |
| 2024 | -1.22x | $-109.07 Million | $89.74 Million | ▼ -565.4% |
| 2023 | -0.18x | $-91.41 Million | $500.43 Million | ▼ -400.5% |
| 2022 | 0.06x | $29.72 Million | $488.91 Million | ▼ -56.3% |
| 2021 | 0.14x | $24.26 Million | $174.54 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.